# A Study to Evaluate Absorption, Metabolism, and Excretion of 14C-JNJ26489112 in Healthy Male Participants

> **NCT01949610** · PHASE1 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 10 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** 14C-JNJ26489112

## Key facts

- **NCT ID:** NCT01949610
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2013-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01949610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01949610, "A Study to Evaluate Absorption, Metabolism, and Excretion of 14C-JNJ26489112 in Healthy Male Participants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01949610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*